These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26039098)

  • 1. Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity.
    Di Cesare Mannelli L; Pacini A; Corti F; Boccella S; Luongo L; Esposito E; Cuzzocrea S; Maione S; Calignano A; Ghelardini C
    PLoS One; 2015; 10(6):e0128080. PubMed ID: 26039098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
    Zanardelli M; Micheli L; Cinci L; Failli P; Ghelardini C; Di Cesare Mannelli L
    PLoS One; 2014; 9(7):e102758. PubMed ID: 25036594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.
    Luongo L; Guida F; Boccella S; Bellini G; Gatta L; Rossi F; de Novellis V; Maione S
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):45-54. PubMed ID: 23394524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial role in oxaliplatin-induced neuropathic pain.
    Di Cesare Mannelli L; Pacini A; Micheli L; Tani A; Zanardelli M; Ghelardini C
    Exp Neurol; 2014 Nov; 261():22-33. PubMed ID: 24967684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
    Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
    Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights.
    Marmiroli P; Riva B; Pozzi E; Ballarini E; Lim D; Chiorazzi A; Meregalli C; Distasi C; Renn CL; Semperboni S; Morosi L; Ruffinatti FA; Zucchetti M; Dorsey SG; Cavaletti G; Genazzani A; Carozzi VA
    PLoS One; 2017; 12(10):e0186250. PubMed ID: 29020118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
    Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain.
    Di Cesare Mannelli L; Pacini A; Bonaccini L; Zanardelli M; Mello T; Ghelardini C
    J Pain; 2013 Dec; 14(12):1585-600. PubMed ID: 24135431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models.
    Cho ES; Yi JM; Park JS; Lee YJ; Lim CJ; Bang OS; Kim NS
    BMC Complement Altern Med; 2016 Oct; 16(1):419. PubMed ID: 27782842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.
    Di Cesare Mannelli L; Pacini A; Matera C; Zanardelli M; Mello T; De Amici M; Dallanoce C; Ghelardini C
    Neuropharmacology; 2014 Apr; 79():37-48. PubMed ID: 24225197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?
    Di Cesare Mannelli L; Pacini A; Micheli L; Femia AP; Maresca M; Zanardelli M; Vannacci A; Gallo E; Bilia AR; Caderni G; Firenzuoli F; Mugelli A; Ghelardini C
    Sci Rep; 2017 Feb; 7():42021. PubMed ID: 28186109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
    Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
    BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transient receptor potential vanilloid receptor 1 and peroxisome proliferator-activated receptors-α in mediating the antinociceptive effects of palmitoylethanolamine in rats.
    Aldossary SA; Alsalem M; Kalbouneh H; Haddad M; Azab B; Al-Shboul O; Mustafa AG; Obiedat S; El-Salem K
    Neuroreport; 2019 Jan; 30(1):32-37. PubMed ID: 30418420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin Regulates Chemotherapy Induced Peripheral Neuropathic Pain in the Dorsal Horn and Dorsal Root Ganglion via the Calcineurin/NFAT Pathway.
    Huang W; Huang J; Jiang Y; Huang X; Xing W; He Y; Ouyang H
    Anticancer Agents Med Chem; 2018; 18(8):1197-1207. PubMed ID: 29793414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy.
    Di Cesare Mannelli L; Zanardelli M; Landini I; Pacini A; Ghelardini C; Mini E; Bencini A; Valtancoli B; Failli P
    Free Radic Biol Med; 2016 Apr; 93():67-76. PubMed ID: 26828020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.
    Di Cesare Mannelli L; D'Agostino G; Pacini A; Russo R; Zanardelli M; Ghelardini C; Calignano A
    Mediators Inflamm; 2013; 2013():328797. PubMed ID: 23533304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis.
    Campolo M; Lanza M; Paterniti I; Filippone A; Ardizzone A; Casili G; Scuderi SA; Puglisi C; Mare M; Memeo L; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay of morphine tolerance by palmitoylethanolamide.
    Di Cesare Mannelli L; Corti F; Micheli L; Zanardelli M; Ghelardini C
    Biomed Res Int; 2015; 2015():894732. PubMed ID: 25874232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
    Impellizzeri D; Cordaro M; Bruschetta G; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
    J Neurotrauma; 2017 Sep; 34(18):2609-2623. PubMed ID: 28095731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.